Downingtown, PA, United States of America

Robert Chapman

USPTO Granted Patents = 18 (Patent Applications = 16)

CIPO Patents = 3

EPO Patents = 9 (Patent Applications = 5)

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 621(Granted Patents)

Location History:

North Kingstown, RI (US) (2006 - 2015)
Downingtown, PA (US) (2014 - 2022)
Downington, PA (US) (2024)

Company Filing History:

Purdue Pharmaceuticals L.p.

The P.f. Laboratories, Inc.

where one patent can have more than one assignee

Years Active: 2006-2024

Loading Chart...

18 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12060361 - Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone (2024-08-13),

2. 11384091 - Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone (2022-07-12),

3. 11236098 - Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone (2022-02-01),

4. 10696684 - Process for preparing oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone (2020-06-30),

5. 10689389 - Process for preparing oxycodone compositions (2020-06-23),

6. 10407434 - Process for preparing oxycodone compositions (2019-09-10),

7. 10259819 - Process for preparing oxycodone compositions (2019-04-16),

8. 9777011 - Process for preparing oxycodone compositions (2017-10-03),

9. 9522919 - Oxycodone compositions (2016-12-20),

10. 9073933 - Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone (2015-07-07),

11. 9044453 - Long-acting injectable moxidectin formulations and novel moxidectin crystal forms (2015-06-02),

12. 8822687 - 8a,14-dihydroxy-7,8-dihydrocodeinone (2014-09-02),

13. 8715711 - Long-acting injectable moxidectin formulations and novel moxidectin crystal forms (2014-05-06),

14. 7683072 - Oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone (2010-03-23),

15. 7674800 - Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone (2010-03-09),

Title: The Innovative Journey of Robert Chapman from Downingtown, PA

Introduction

Robert Chapman, hailing from Downingtown, PA, is a prolific inventor with an impressive portfolio of 18 patents. His work predominantly revolves around the pharmaceutical industry, where his contributions have significantly impacted medication formulations and safety.

Latest Patents

Among his latest innovations, Robert has developed a process for preparing oxycodone hydrochloride, which ensures that the final composition contains less than 25 parts per million of 14-hydroxycodeinone. This invention emphasizes the importance of quality and safety in pharmaceuticals, aiming to provide patients with effective yet safer medication options.

Career Highlights

Throughout his career, Robert has made noteworthy advancements in the pharmaceutical field, particularly during his tenure at Purdue Pharma L.P. and Purdue Pharmaceuticals L.P. His expertise in chemical processes and formulation have positioned him as a key player in the industry, contributing to groundbreaking developments.

Collaborations

Robert's journey is marked by collaboration with esteemed colleagues such as Lonn S. Rider and Qi Hong. Together, they have shared knowledge and insights, driving innovation further in their projects and enhancing the overall quality of the products they have worked on.

Conclusion

Robert Chapman continues to be a vital contributor to the field of pharmaceuticals with his inventive processes and dedication to medication safety. His innovative spirit and collaborative efforts pave the way for future advancements that promise to improve patient care and treatment efficacy.

This text is generated by artificial intelligence and may not be accurate.